Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma

CONCLUSION: Percutaneous Hepatic Perfusion is safe and associated with a transient, asymptomatic troponin elevation peri-operatively without major adverse cardiac events at 90 days. The observed troponin elevation is likely secondary to coronary demand-supply mismatch related to procedural hemodynamic shifts, hypotension, and anemia.PMID:38605434 | DOI:10.1177/10732748241246898

Source: Cancer Control - April 12, 2024 Category: Cancer & Oncology Authors: Sanjay Chandrasekhar Matthew Perez Zurain Niaz Jahanzaib Ekram Neelam Lal Sarah Koly Biwei Cao Jonathan S Zager Mohammed Alomar Source Type: research